WuXi AppTec Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003F19
HKD
124.90
1 (0.81%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

5.04 M

Shareholding (Jun 2024)

FII

0.00%

Held by 1 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

High Management Efficiency with a high ROE of 16.30%

 
2

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 43.26

 
3

Healthy long term growth as Net Sales has grown by an annual rate of 22.19% and Operating profit at 40.11%

 
4

Flat results in Dec 18

5

With ROE of 25.75%, it has a Fair valuation with a 0.64 Price to Book Value

6

Market Beating performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

HKD 63,861 Million ()

stock-summary
P/E

2.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.14

stock-summary
Return on Equity

23.61%

stock-summary
Price to Book

0.82

Revenue and Profits:
Net Sales:
12,034 Million
(Quarterly Results - Dec 2025)
Net Profit:
6,537 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
23.66%
0%
23.66%
6 Months
2.88%
0%
2.88%
1 Year
82.2%
0%
82.2%
2 Years
239.86%
0%
239.86%
3 Years
51.95%
0%
51.95%
4 Years
0.56%
0%
0.56%
5 Years
-23.19%
0%
-23.19%

WuXi AppTec Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
22.19%
EBIT Growth (5y)
40.11%
EBIT to Interest (avg)
43.26
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
0.66
Tax Ratio
14.88%
Dividend Payout Ratio
30.07%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
19.62%
ROE (avg)
16.30%

Valuation key factors

Factor
Value
P/E Ratio
2
Industry P/E
Price to Book Value
0.64
EV to EBIT
1.78
EV to EBITDA
1.78
EV to Capital Employed
0.53
EV to Sales
0.59
PEG Ratio
0.04
Dividend Yield
NA
ROCE (Latest)
29.50%
ROE (Latest)
25.75%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -8.57% vs 9.45% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 68.62% vs -25.23% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "12,034.00",
          "val2": "13,161.60",
          "chgp": "-8.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4,995.70",
          "val2": "4,959.30",
          "chgp": "0.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "49.80",
          "val2": "97.10",
          "chgp": "-48.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6,537.00",
          "val2": "3,876.70",
          "chgp": "68.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "415.10%",
          "val2": "376.80%",
          "chgp": "3.83%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 21.43% vs -9.27% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 58.46% vs -1.58% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "47,090.90",
          "val2": "38,779.20",
          "chgp": "21.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "20,900.50",
          "val2": "15,179.80",
          "chgp": "37.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "323.50",
          "val2": "233.60",
          "chgp": "38.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-148.70",
          "val2": "202.70",
          "chgp": "-173.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "19,545.80",
          "val2": "12,334.60",
          "chgp": "58.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "362.90%",
          "val2": "316.50%",
          "chgp": "4.64%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
12,034.00
13,161.60
-8.57%
Operating Profit (PBDIT) excl Other Income
4,995.70
4,959.30
0.73%
Interest
49.80
97.10
-48.71%
Exceptional Items
0.00
0.00
Consolidate Net Profit
6,537.00
3,876.70
68.62%
Operating Profit Margin (Excl OI)
415.10%
376.80%
3.83%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is -8.57% vs 9.45% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 68.62% vs -25.23% in Sep 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
47,090.90
38,779.20
21.43%
Operating Profit (PBDIT) excl Other Income
20,900.50
15,179.80
37.69%
Interest
323.50
233.60
38.48%
Exceptional Items
-148.70
202.70
-173.36%
Consolidate Net Profit
19,545.80
12,334.60
58.46%
Operating Profit Margin (Excl OI)
362.90%
316.50%
4.64%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 21.43% vs -9.27% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 58.46% vs -1.58% in Dec 2024

stock-summaryCompany CV
About WuXi AppTec Co., Ltd. stock-summary
stock-summary
WuXi AppTec Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available